Marc Oliver Grimm

Friedrich Schiller Universität Jena - Jena / Germany

Others

AD Scientific Index ID: 1758222

Friedrich Schiller University Jena

Registration, Add Profile,
Premium Membership

Print Your Certificate

Marc Oliver Grimm's MOST POPULAR ARTICLES

1-) Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinomaRJ Motzer, NM Tannir, DF McDermott, OA Frontera, B Melichar, ...New England Journal of Medicine, 201830702018

2-) Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trialP Sharma, M Retz, A Siefker-Radtke, A Baron, A Necchi, J Bedke, ...The lancet oncology 18 (3), 312-322, 201714152017

3-) Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised …RJ Motzer, BI Rini, DF McDermott, OA Frontera, HJ Hammers, ...The Lancet Oncology 20 (10), 1370-1385, 20195062019

4-) Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trialL Albiges, NM Tannir, M Burotto, D McDermott, ER Plimack, P Barthélémy, ...ESMO open 5 (6), e001079, 20205342020

5-) Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational studyMO Grimm, C Steinhoff, X Simon, P Spiegelhalder, R Ackermann, ...The Journal of urology 170 (2), 433-437, 20034782003

ARTICLES

Add your articles